Correlation Between Agilent Technologies and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Travere Therapeutics, you can compare the effects of market volatilities on Agilent Technologies and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Travere Therapeutics.
Diversification Opportunities for Agilent Technologies and Travere Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agilent and Travere is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Agilent Technologies and Travere Therapeutics
Taking into account the 90-day investment horizon Agilent Technologies is expected to under-perform the Travere Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Agilent Technologies is 2.75 times less risky than Travere Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,969 in Travere Therapeutics on August 29, 2024 and sell it today you would lose (63.00) from holding Travere Therapeutics or give up 3.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agilent Technologies vs. Travere Therapeutics
Performance |
| Timeline |
| Agilent Technologies |
| Travere Therapeutics |
Agilent Technologies and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agilent Technologies and Travere Therapeutics
The main advantage of trading using opposite Agilent Technologies and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Agilent Technologies vs. Danaher | Agilent Technologies vs. Illumina | Agilent Technologies vs. IDEXX Laboratories | Agilent Technologies vs. Waters |
| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |